Frequently Asked Questions

Conference Speakers

Cultural Speakers

Cultural practices, beliefs, and norms play a very important role not only in delivering health care to clients and patients, but also in how that health care is received and what outcomes are possible. Diversity within those beliefs and practices, and as a result of available resources or social economic/demographic circumstances, must be fully understood in order for health care professionals to provide the best care possible no matter where they are in the world, or what culture they are practicing within.

At GOLD Perinatal Care, we understand the importance of Culture and Diversity in health care, and we are working hard to bring you speakers and presentations from around the world that will help you understand the patients and clients you are working with. Discovering how health care is provided and received in other countries and cultures around the world can have a positive impact on our own professional practice. Given that culture is defined by much more than political borders, GOLD Perinatal Care invites speakers to share their knowledge and expertise about perinatal health care from a geographically-based focus or a people-group focus from within a particular set of beliefs, lifestyle or minority. This year, our Culture and Diversity speakers will be presenting on:

- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Dr. Second Speaker Name
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
View Registration Info
Speakers

Speakers (5191)

Sunday, 08 August 2021 11:18

Regine Deniel Ihlen

Written by
Sunday, 08 August 2021 11:18

Lavinia Magee

Written by
Sunday, 08 August 2021 11:18

Tommy Björk

Written by
Sunday, 08 August 2021 11:18

Alfonso Aguarón

Written by
Sunday, 08 August 2021 11:18

Diego Villalón

Written by
Sunday, 08 August 2021 11:18

Teri Kennedy

Written by
Sunday, 08 August 2021 11:18

Anita Figueras

Written by
Sunday, 08 August 2021 11:18

Ivy B. Elkins

Written by
Ivy Elkins is one of the co-founders of the EGFR Resisters, a patient-driven initiative to understand and improve treatments for EGFR+ lung cancer through collaborations with researchers and advocacy groups. She is a dedicated advocate for lung cancer research, having served se times as a consumer reviewer for the Department of Defense Lung Cancer Research Program, reviewed grant proposals for ASCO’s Conquer Cancer, twice completed the AACR Scientist-Survivor program, mentored other research advocates through the IASLC STARS program and acted as advocate faculty for four years for the ASCO/AACR Methods in Clinical Cancer Research Workshop.

In addition, Ivy serves on the Yale SPORE, the Patient Advocacy committee for IASLC, the Editorial Group for the International Lung Cancer News (ILCN) and the UChicago Medicine Community External Advisory Committee. She also writes for lungcancer.net and frequently shares her patient perspective with the media, pharmaceutical companies, and other industry members involved in the lung cancer community.

Currently NED, Ivy was diagnosed in December 2013 with EGFR+ stage IV lung cancer that had metastasized to her bones and brain. She has been treated at both the University of Chicago and Northwestern Medicine and lives in the Chicago suburbs with her husband Ben and her two teenaged boys. She has an undergraduate degree in English from Princeton University and a Master’s in Business Administration from the Wharton School at the University of Pennsylvania.
Sunday, 08 August 2021 11:18

Riddhi Thakrar

Written by
Page 235 of 371